Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nitrofurantoin 7.5mg/5ml oral liquid
0501130R0AAAXAX
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 7.8mg/5ml oral liquid
0501130R0AACJCJ
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 75mg/5ml oral liquid
0501130R0AABKBK
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 7mg/5ml oral liquid
0501130R0AABBBB
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 8mg/5ml oral liquid
0501130R0AABLBL
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 9.5mg/5ml oral liquid
0501130R0AABTBT
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 9mg/5ml oral liquid
0501130R0AABABA
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nivaquine 200mg tablets
0504010G0BBAAAC
|
Nivaquine | Chloroquine sulfate | Infections | No data available |
|
Nivaquine 200mg/5ml solution for injection ampoules
0504010G0BBACAA
|
Nivaquine | Chloroquine sulfate | Infections | No data available |
|
Nivaquine 68mg/5ml syrup
0504010G0BBABAF
|
Nivaquine | Chloroquine sulfate | Infections | No data available |
|
Nivemycin 500mg tablets
0501040N0BCAAAD
|
Nivemycin (Systemic) | Neomycin sulfate | Infections | No data available |
|
Nizoral 200mg tablets
0502020A0BBAAAC
|
Nizoral (Systemic) | Ketoconazole | Infections | No data available |
|
Normix 100mg/5ml granules for oral suspension
0501070X0BBABAC
|
Normix | Rifaximin | Infections | No data available |
|
Normix 200mg tablets
0501070X0BBAAAA
|
Normix | Rifaximin | Infections | No data available |
|
Norvir 100mg capsules
0503010U0BBACAA
|
Norvir | Ritonavir | Infections | No data available |
|
Norvir 100mg oral powder sachets
0503010U0BBAEAD
|
Norvir | Ritonavir | Infections | No data available |
|
Norvir 100mg tablets
0503010U0BBADAC
|
Norvir | Ritonavir | Infections | No data available |
|
Norvir 80mg/ml oral solution
0503010U0BBABAB
|
Norvir | Ritonavir | Infections | No data available |
|
Norzol 200mg/5ml oral suspension
0501110C0BKAAAE
|
Norzol | Metronidazole | Infections | No data available |
|
Noxafil 100mg gastro-resistant tablets
0502010A0BBABAB
|
Noxafil | Posaconazole | Infections | No data available |
|
Noxafil 300mg/10ml gastro-resistant pdr and solvent for susp
0502010A0BBADAD
|
Noxafil | Posaconazole | Infections | No data available |
|
Noxafil 300mg/16.7ml concentrate for inf vials
0502010A0BBACAC
|
Noxafil | Posaconazole | Infections | No data available |
|
Noxafil 40mg/ml oral suspension
0502010A0BBAAAA
|
Noxafil | Posaconazole | Infections | No data available |
|
Nystamont 100,000units/ml oral suspension
0502030B0BGAAAX
|
Nystamont | Nystatin | Infections | No data available |
|
Nystan 500,000unit tablets
0502030B0BBAAAI
|
Nystan (Systemic) | Nystatin | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.